David E. Lazar sold $5.8M of Cyclacel Pharmaceuticals (CYCC)

Executed Feb 26 2025, disclosed Feb 28 2025, 2 days later.

Value, as filed

$5.8M

194,628,820 sh × $0.03

Executed

Feb 26 2025

the trade date, as filed

Disclosed

Feb 28 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DL David E. Lazar Interim CEO profile →

David E. Lazar (Interim CEO) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in CYCC. The largest single filing was $5.8M of CYCC (194,628,820 sh × $0.03, as filed), executed Feb 26 2025.

The name

CYCC CYCC CYCC · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→